UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549



FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


Date of Report (Date of earliest event reported): August 6, 2009


AMN Healthcare Services, Inc.
(Exact Name of Registrant as Specified in its Charter)

Delaware
001-16753
06-1500476
(State or other Jurisdiction
of Incorporation)
(Commission File Number)
(I.R.S. Employer
Identification No.)
     
12400 High Bluff Drive, Suite 100
92130
(Address of Principal Executive Offices)
(Zip Code)

Registrant's telephone number, including area code:  (866) 871-8519

Not Applicable
(Former name or former address, if changed from last report)



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 

 

Section 2 – Financial Information
 
Item 2.02
Results of Operations and Financial Condition.
 
On August 6, 2009, AMN Healthcare Services, Inc. (the “Company”) reported its second quarter 2009 results. The Company’s second quarter 2009 results are discussed in detail in the press release which is furnished as Exhibit 99.1 to this Form 8-K and incorporated herein by reference.
 
The information in this Item 2.02 and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except to the extent as shall be expressly set forth by specific reference in such filing.

 
Item 9.01 
Financial Statements and Exhibits

(d) Exhibits

99.1
Press Release issued by the Company on August 6, 2009 furnished pursuant to Item 2.02 of this Form 8-k
 
 
 

 
 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
AMN Healthcare Services, Inc.
 
       
Date: August 6, 2009
By:
/s/ Susan R. Nowakowski   
    Susan R. Nowakowski   
   
President & Chief Executive Officer
 
       
 
 
 

 
 
   
Contact:
Amy C. Chang
Vice President, Investor Relations
866.861.3229
 


FOR IMMEDIATE RELEASE

AMN HEALTHCARE ANNOUNCES SECOND QUARTER 2009 RESULTS

SAN DIEGO – (August 6, 2009) – AMN Healthcare Services, Inc. (NYSE: AHS) today announced operating results for the second quarter 2009, which were in line with management’s expectations. Financial highlights for the three months ended June 30, 2009 include:
 
   
 Q2 2009
   
% Chg
Q2 2008
   
% Chg
Q1 2009
 
Revenue
 
$199 million
     
(36%)
   
(20%)
 
Net Income
 
$4 million
     
(49%)
   
NM
 
Diluted EPS
 
$0.13
     
(48%)
   
NM
 
Cash Flow from Operations
 
$36 million
     
206%
   
(3%)
 
Adjusted EBITDA*
 
$18 million
     
(27%)
   
3%
 
Adjusted Diluted EPS*
 
$0.17
 
   
(32%)
   
55%
 
* See “Supplemental Financial and Operating Data” for a reconciliation of non-GAAP items.
NM – Not meaningful

“Our focus on client relationships and quality as well as our diversified service offerings have enabled AMN Healthcare to maintain our leading market position, improve gross margins and strengthen our balance sheet through the prolonged economic downturn,” said Susan R. Nowakowski, President and Chief Executive Officer of AMN Healthcare. “We continue to take an aggressive and disciplined approach in streamlining and right-sizing our infrastructure, enabling us to adjust to short-term volume trends, while operating with an improved cost structure going forward. At the same time, we are also maintaining our long-term strategy of investing in our future through progress with new service lines.”


 
Key business highlights include:
·  
Strong market leadership position, with stable pricing and gross margins across service lines;
·  
Signs of stabilization and improvement in Nursing and Allied orders;
·  
Progress in new market expansion areas of Emergency Medicine Physician staffing, Home Health Nurse and Allied staffing, and Recruitment Process Outsourcing;
·  
Significant debt reduction and increased cash that position the company to capture additional market opportunities for future growth;
·  
Cost structure improvements and more streamlined infrastructure for improved profitability as the market rebounds.

For the second quarter of 2009, revenue for the Nurse and Allied staffing segment was $111 million, a decrease of 48% from the same quarter last year and 32% sequentially. The Locum Tenens staffing segment generated revenue of $79 million, a decrease of 6% from the same quarter last year and an increase of 6% sequentially.

Gross margin in the second quarter of 2009 was 27.0%, an increase of 140 bps as compared to 25.6% for the previous quarter and an increase of 60 bps as compared to 26.4% for the same quarter last year. The year over year and sequential increase mainly reflected a shift in business mix and tight management of direct costs.

Selling, general and administrative ("SG&A") expenses (excluding restructuring costs) for the second quarter of 2009 were 19.0% as a percentage of revenue as compared to 19.2% in the same quarter last year. SG&A declined by $22.3 million, or 37%, over the same period in the prior year and by $12.2 million, or 24%, sequentially, due to cost-saving initiatives taking hold as well as $3.5 million in favorable insurance reserve adjustments.

As a result of certain cost-reduction actions, the company recorded $2.2 million in restructuring charges, consisting mainly of severance payments and lease-related charges associated with various facility, branding and back-office consolidations.

2

Second quarter GAAP net earnings per diluted share was $0.13, including a $0.04 negative impact from restructuring charges, reflecting a decrease compared to $0.25 in the same period in the prior year.

As of June 30, 2009 cash and cash equivalents totaled $23.5 million, compared to $11.3 million as of December 31, 2008. Total debt outstanding was $90.0 million as of June 30, 2009, reflecting a reduction in debt of $56.3 million since December 31, 2008. Total average diluted shares outstanding for the second quarter of 2009 were 32.9 million.

Business Trends and Outlook
During the second quarter of 2009, Nursing and Allied orders continued to show signs of stabilization, although still at levels significantly lower than prior year. Locum Tenens volume (days filled) increased slightly over the first quarter. Pricing and gross margins remained relatively stable overall.

Nowakowski noted continued signs of stabilization and some recent improvement in orders for travel nurse and allied professionals which should translate into stabilizing volumes during the third quarter. Locum Tenens volume and physician permanent placements are expected to be steady compared with the prior quarter. Based on these trends, third quarter consolidated revenue is expected to decline sequentially by approximately 15%. The majority of this decline is driven by volume trends in nurse staffing resulting from the earlier drop in demand levels. Overall gross margins are anticipated to remain consistent.

“We are continuing to focus on maintaining strong relationships and securing preferred contracts with our clients, as well as nurturing our recent new service offerings such as Emergency Medicine staffing, Home Health staffing, and Recruitment Process Outsourcing,” added Nowakowski. “At the same time, we are prudently managing our cost structure and balance sheet in order to position ourselves for future investments in new market opportunities that contribute strategic synergies to our core service lines. Despite the uncertainty of when economic recovery will occur, we remain confident in the long-term fundamentals of our industry and focused on laying the groundwork for innovation and growth in future years to drive shareholder value.”

3

About AMN Healthcare Services
AMN Healthcare Services, Inc. is the largest healthcare staffing company in the United States and a leader in all three of its business segments: travel nurse and allied staffing, locum tenens staffing (temporary physician staffing), and physician permanent placement services. AMN Healthcare recruits healthcare professionals both nationally and internationally and places them on variable lengths of assignments and in permanent positions at acute-care hospitals, physician practice groups and other healthcare settings throughout the United States. For more information, visit http://www.amnhealthcare.com.

Conference Call on August 6, 2009
AMN Healthcare Services, Inc.'s second quarter 2009 conference call will be held on Thursday, August 6, 2009, at 5:00 p.m., Eastern Time. A live webcast of the call can be accessed through AMN Healthcare's website at http://www.amnhealthcare.com/investors. Please log in at least 10 minutes prior to the conference call in order to download the applicable audio software. Interested parties may participate live via telephone by dialing (800) 230-1092 in the U.S. or (612) 332-0335 internationally. Following the conclusion of the call, a replay of the webcast will be available at the company's website. Alternatively, a telephonic replay of the call will be available at 7:30 p.m. Eastern Time on August 6, 2009, and can be accessed until August 20, 2009 at midnight Eastern Time, by calling (800) 475-6701 in the U.S. or (320) 365-3844 internationally, with access code 106454.

Non-GAAP Measures
This earnings release contains certain non-GAAP financial information. These measures are not in accordance with, or an alternative to, generally accepted accounting principles in the United States ("GAAP"), and may be different from non-GAAP measures reported by other companies. From time to time, additional information regarding non-GAAP financial measures may be made available on the Company's website at http://www.amnhealthcare.com/investors.

 
4

Forward-Looking Statements
 
 
This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The company based these forward-looking statements on its current expectations and projections about future events. Actual results could differ materially from those discussed in, or implied by, these forward-looking statements. Forward-looking statements are identified by words such as "believe," "anticipate," "expect," "intend," "plan," "will," "may" and other similar expressions. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements. Factors that could cause actual results to differ from those implied by the forward-looking statements contained in this press release are set forth in the company's Annual Report on Form 10-K for the year ended December 31, 2008 and its other quarterly and periodic reports filed with the SEC. These statements reflect the company's current beliefs and are based upon information currently available to it. Be advised that developments subsequent to this press release are likely to cause these statements to become outdated with the passage of time.
 
5

 


 
 
 
AMN Healthcare Services, Inc.
Condensed Consolidated Statements of Income
(dollars in thousands, except per share amounts)
(unaudited)


   
Three Months Ended
 June 30,
         
Six Months Ended
 June 30,
       
   
2009
   
2008
   
% Chg
   
2009
   
2008
   
% Chg
 
                                     
Revenue                                             
  $ 199,140     $ 312,691       (36.3 %)   $ 448,735     $ 606,284       (26.0 %)
Cost of revenue
    145,463       230,153       (36.8 %)     331,075       446,291       (25.8 %)
Gross profit
    53,677       82,538       (35.0 %)     117,660       159,993       (26.5 %)
      27.0 %     26.4 %             26.2 %     26.4 %        
Operating expenses:
                                               
   Selling, general and administrative
    37,840       60,117       (37.1 %)     87,920       115,220       (23.7 %)
      19.0 %     19.2 %             19.6 %     19.0 %        
                                                 
   Restructuring Charges
    2,152             100 %     5,070             100 %
   Impairment Charges
                0 %     175,707             100 %
   Depreciation and amortization
    3,442       3,738       (7.9 %)     6,909       7,088       (2.5 %)
                                                 
Total operating expenses
    43,434       63,855       (32.0 %)     275,606       122,308       125.3 %
Income (loss) from operations
    10,243       18,683       (45.2 %)     (157,946 )     37,685    
NM
 
      5.1 %     6.0 %             (35.2 %)     6.2 %        
Interest expense, net
    2,320       2,660       (12.8 %)     4,519       5,471       (17.4 %)
Income (loss) before income taxes
    7,923       16,023       (50.6 %)     (162,465 )     32,214    
NM
 
Income tax expense
    3,549       7,508       (52.7 %)     (45,005 )     14,976    
NM
 
Net income (loss)
  $ 4,374     $ 8,515       (48.6 %)   $ (117,460 )   $ 17,238    
NM
 
      2.2 %     2.7 %             (26.2 %)     2.8 %        
Net income (loss) per common share:
                                               
      Basic
  $ 0.13     $ 0.25       (48.0 %)   $ (3.60 )   $ 0.51    
NM
 
      Diluted
  $ 0.13     $ 0.25       (48.0 %)   $ (3.60 )   $ 0.50    
NM
 
                                                 
Weighted average common shares outstanding:
                                               
      Basic
    32,621       33,833       (3.6 %)     32,599       33,832       (3.6 %)
      Diluted
    32,918       34,308       (4.1 %)     32,599       34,244       (4.8 %)
                                                 

NM – Not meaningful

6


 
AMN Healthcare Services, Inc.
Supplemental Financial and Operating Data
(dollars in thousands, except operating data)
(unaudited)
 
 
 
 
   
Three Months Ended
June 30,
   
Six Months Ended
June 30,
 
   
2009
   
% of Rev
   
2008
   
% of Rev
   
2009
   
% of Rev
   
2008
   
% of Rev
 
Revenue
                                               
  Nurse and allied healthcare staffing
  $ 111,136           $ 215,342           $ 274,986           $ 419,327        
  Locum tenens staffing
    79,097             83,857             153,888             160,210        
  Physician permanent placement services
    8,907             13,492             19,861             26,747        
    $ 199,140           $ 312,691           $ 448,735           $ 606,284        
                                                         
Reconciliation of Non-GAAP Items:
                                                       
Adjusted EBITDA(1)
                                                       
  Nurse and allied healthcare staffing
  $ 6,796       6.1 %   $ 16,692       7.8 %   $ 17,387       6.3 %   $ 32,173       7.7 %
  Locum tenens staffing
    8,985       11.4 %     4,247       5.1 %     12,806       8.3 %     9,902       6.2 %
  Physician permanent placement services
    2,211       24.8 %     3,864       28.6 %     5,261       26.5 %     7,203       26.9 %
      17,992       9.0 %     24,803       7.9 %     35,454       7.9 %     49,278       8.1 %
                                                                 
Depreciation and amortization
    3,442               3,738               6,909               7,088          
Stock-based compensation
    2,155               2,382               4,830               4,505          
Restructuring charges
    2,152                             5,070                        
Impairment charges
                                175,707                        
Non-recurring legal expenses
                                884                        
Interest expense, net
    2,320               2,660               4,519               5,471          
Income (loss) before income taxes
    7,923               16,023               (162,465 )             32,214          
Income tax expense
    3,549               7,508               (45,005 )             14,976          
Net income (loss)
  $ 4,374             $ 8,515             $ (117,460 )           $ 17,238          
                                                                 
                                                                 
GAAP based diluted net income (loss)
 per share (EPS)
  $ 0.13                             $ (3.60 )                        
  Adjustments:
                                                               
  Restructuring charges
    0.04                               0.09                          
  Impairment charges
                                  3.77                          
  Non-recurring legal expenses
                                  0.02                          
Adjusted diluted earnings per share (2)
  $ 0.17                             $ 0.28                          
 
   
Three Months Ended
June 30,
           
Six Months Ended
June 30,
         
   
2009
   
2008
   
% Chg
   
2009
   
2008
   
% Chg
 
Gross Margin
                                               
   Nurse and allied healthcare staffing
    25.0 %     24.5 %             23.8 %     24.3 %        
   Locum tenens staffing
    26.1 %     25.8 %             26.2 %     26.3 %        
   Physician permanent placement services
    58.8 %     59.7 %             60.3 %     60.6 %        
                                                 
Operating Data:
                                               
Nurse and allied healthcare staffing
                                               
    Average travelers on assignment (3)
    3,661       7,207       (49.2 %)     4,575       7,047       (35.1 %)
    Revenue per traveler per day(4)
  $ 333.59     $ 328.35       1.6 %   $ 332.08     $ 326.95       1.6 %
    Gross profit per traveler per day(4)
  $ 83.36     $ 80.52       3.5 %   $ 78.99     $ 79.30       (0.4 %)
                                                 
Locum tenens  staffing
                                               
    Days filled (5)
    54,708       57,859       (5.4 %)     107,105       110,558       (3.1 %)
    Revenue per day filled(5)
  $ 1,445.80     $ 1,449.33       (0.2 %)   $ 1,436.80     $ 1,449.10       (0.8 %)
    Gross profit per day filled(5)
  $ 377.79     $ 374.62       0.8 %   $ 375.94     $ 380.50       (1.2 %)
                                                 
                                                 
   
As of June 30,
                                 
   
2009
   
2008
                                 
                                             
Leverage Ratio (6)
    1.1       1.6                                  
                                                 
                                                 

7


(1)  
Adjusted EBITDA represents net income (loss) plus interest expense (net of interest income), income taxes, depreciation and amortization, restructuring charges, impairment charges, non-recurring legal expenses and stock-based compensation expense. Management presents adjusted EBITDA because it believes that adjusted EBITDA is a useful supplement to net income as an indicator of operating performance. Management believes that adjusted EBITDA is an industry wide financial measure that is useful both to management and investors when evaluating the company’s performance. Management also uses adjusted EBITDA for planning purposes. Management uses adjusted EBITDA to evaluate the company’s performance because it believes that adjusted EBITDA more accurately reflects the company’s results, as it excludes certain items, in particular stock-based compensation charges that management believes are not indicative of the company’s operating performance. However, adjusted EBITDA is not intended to represent cash flows for the period, nor has it been presented as an alternative to operating or net income as an indicator of operating performance, and it should not be considered in isolation or as a substitute for measures of performance prepared in accordance with GAAP. As defined, adjusted EBITDA is not necessarily comparable to other similarly titled captions of other companies due to potential inconsistencies in the method of calculation. While management believes that some of the items excluded from adjusted EBITDA are not indicative of the company’s operating performance, these items do impact the income statement, and management therefore utilizes adjusted EBITDA as an operating performance measure in conjunction with GAAP measures such as net income.
(2)  
Adjusted EPS represents GAAP EPS plus restructuring and impairment charges and non-recurring legal expenses. Management presents adjusted EPS because it believes that adjusted EPS is a useful supplement to diluted net loss per share as an indicator of operating performance. Management believes such a measure provides a picture of the company’s results that is more comparable among periods since it excludes the impact of items that may recur occasionally, but tend to be irregular as to timing, thereby distorting comparisons between periods. However, investors should note that this non-GAAP measure involves judgment by management (in particular, judgment as to what is classified as a special item to be excluded from adjusted EPS). As defined, adjusted EPS is not necessarily comparable to other similarly titled captions of other companies due to potential inconsistencies in the method of calculation. While management believes that some of the items excluded from adjusted EPS are not indicative of the company’s operating performance, these items do impact the income statement, and management therefore utilizes adjusted EPS as an operating performance measure in conjunction with GAAP measures such as GAAP EPS.
(3)  
Average travelers on assignment represents the average number of nurse and allied healthcare professionals on assignment during the period presented.
(4)  
Revenue per traveler per day and gross profit per traveler per day represent the revenue and gross profit of the company’s nurse and allied healthcare staffing segment divided by average travelers on assignment, divided by the number of days in the period presented.
(5)  
Days filled is calculated by dividing the locum tenens hours filled during the period by 8 hours. Revenue per day filled and gross profit per day filled represent revenue and gross profit of the company’s locum tenens staffing segment divided by days filled for the period presented.
(6)  
Leverage ratio represents the ratio of the total debt outstanding at the end of the period to the Adjusted EBITDA for the past twelve months.

8



AMN Healthcare Services, Inc.
Condensed Consolidated Balance Sheets
(in thousands)
(unaudited)
 
 
   
June 30,
   
March 31,
   
December 31,
 
   
2009
   
2009
   
2008
 
Assets
                 
Current assets:
                 
  Cash and cash equivalents
  $ 23,488     $ 16,675     $ 11,316  
  Accounts receivable, net
    114,542       148,376       182,562  
  Prepaid expenses
    8,867       10,585       9,523  
  Income taxes receivable
    1,425       4,448       3,440  
  Deferred income taxes, net
    18,085       22,417       18,085  
  Other current assets
    2,911       3,376       4,901  
    Total current assets
    169,318       205,877       229,827  
                         
Fixed assets, net
    24,034       24,938       24,018  
Deposits and other assets
    12,056       10,579       13,252  
Goodwill
    79,868       79,868       252,875  
Intangible assets, net
    117,738       118,940       122,845  
                         
     Total assets
  $ 403,014     $ 440,202     $ 642,817  
                         
Liabilities and stockholders’ equity
                       
Current liabilities:
                       
  Bank overdraft
  $ 3,274     $     $ 3,995  
  Accounts payable and accrued expenses
    20,837       24,667       24,420  
  Accrued compensation and benefits
    31,941       36,728       44,871  
  Revolving credit facility
          6,500       31,500  
  Current portion of notes payable
    12,201       14,824       14,580  
  Deferred revenue
    5,699       6,204       7,184  
  Other current liabilities
    15,892       15,060       14,722  
    Total current liabilities
    89,844       103,983       141,272  
                         
Notes payable, less current portion
    77,781       98,208       100,236  
Deferred income taxes, net
    7,382       13,342       58,466  
Other long-term liabilities
    56,592       59,532       58,710  
    Total liabilities
    231,599       275,065       358,684  
                         
Stockholders’ equity
    171,415       165,137       284,133  
                         
 Total liabilities and stockholders’ equity
  $ 403,014     $ 440,202     $ 642,817  
                         



9





AMN Healthcare Services, Inc.
Condensed Consolidated Cash Flow Statement
(in thousands)
(unaudited)
 
 
 
   
Three Months Ended
   
Six Months Ended
 
   
June 30,
   
June 30,
   
June 30,
   
June 30,
 
   
2009
   
2008
   
2009
   
2008
 
                         
Net cash provided by operating activities
  $ 36,388     $ 11,883     $ 73,945     $ 28,756  
                                 
Net cash used in investing activities
    (1,204 )     (11,064 )     (2,434 )     (44,465 )
                                 
Net cash provided by (used in) financing activities
    (28,420 )     (345 )     (59,374 )     5,589  
                                 
Effect of exchange rates on cash
    49       47       35       (19 )
                                 
  Net increase (decrease) in cash and cash equivalents
    6,813       521       12,172       (10,139 )
                                 
  Cash and cash equivalents at beginning of period
    16,675       7,835       11,316       18,495  
                                 
  Cash and cash equivalents at end of period
  $ 23,488     $ 8,356     $ 23,488     $ 8,356  


 

10